Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03672578 · ClinicalTrials.gov registry record · NA

Reducing Sugar-sweetened Beverage Consumption Among Young Adults

A NA study, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
2,971
Enrollment target

NCT03672578: Completed NA study, sponsored by University of California, Davis.

NCT03672578 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 2,971 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (112% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03672578, a NA study, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
2,971 participants
Enrollment target

Study Summary

This study aims to test sugar-sweetened beverage (SSB) health labeling elements in an online experiment to determine which elements are the most salient among young adults.

Primary Outcome

Intention to consume SSBs measured by hypothetical selection of a beverage from images of beverage options.

Interventions

  • OTHER loss-frame
  • OTHER gain-frame
  • OTHER text-only
  • OTHER icon
  • OTHER attribution

Trial Details

FieldValue
Enrollment Target 2,971 participants
Start Date 2018-08-18
Est. Completion 2018-11-17
Phase NA
University of California, Davis

657 total trials

What the finished NCT03672578 record still lists

NCT03672578 is an interventional study that assigns participants to a tested intervention. Its 2,971 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (112% higher).

The record links to 0 conditions, and to 5 interventions - of which loss-frame is the first listed.

NCT03672578 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03672578 about?

NCT03672578 is a clinical study titled "Reducing Sugar-sweetened Beverage Consumption Among Young Adults". This study aims to test sugar-sweetened beverage (SSB) health labeling elements in an online experiment to determine which elements are the most salient among young adults.

What is the current status of trial NCT03672578?

This trial is currently completed. It is a NA study. The enrollment target is 2,971 participants. The study started on 2018-08-18. Estimated completion is 2018-11-17.

What interventions are being tested in trial NCT03672578?

The interventions under investigation include: loss-frame (OTHER), gain-frame (OTHER), text-only (OTHER), icon (OTHER), attribution (OTHER).

Who is sponsoring clinical trial NCT03672578?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03672578's enrollment target sits among peer trials

2,971 43rd of 2000 higher than 1,958 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03331380 · 2,950 participants · NA

    Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System

  • NCT05297734 · 2,996 participants · NA

    Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

  • NCT05849961 · 2,946 participants

    Exactech Hip Systems Post-Market Clinical Follow-up (PMCF)

  • NCT03860883 · 2,998 participants · NA

    Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03672578, the US trial registry maintained by the National Library of Medicine. NCT03672578 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.